Farther Finance Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.27K | Sell |
230
-332
| -59% | -$11.9K | ﹤0.01% | 3163 |
|
2025
Q1 | $21.2K | Buy |
562
+359
| +177% | +$13.6K | ﹤0.01% | 2360 |
|
2024
Q4 | $6.11K | Sell |
203
-28
| -12% | -$842 | ﹤0.01% | 2578 |
|
2024
Q3 | $5.4K | Buy |
231
+18
| +8% | +$421 | ﹤0.01% | 2611 |
|
2024
Q2 | $3.86K | Buy |
213
+26
| +14% | +$472 | ﹤0.01% | 2510 |
|
2024
Q1 | $2.76K | Buy |
187
+27
| +17% | +$399 | ﹤0.01% | 2356 |
|
2023
Q4 | $2.73K | Buy |
160
+60
| +60% | +$1.03K | ﹤0.01% | 2293 |
|
2023
Q3 | $836 | Buy |
+100
| New | +$836 | ﹤0.01% | 2123 |
|
2023
Q1 | – | Sell |
-95
| Closed | -$1.12K | – | 2434 |
|
2022
Q4 | $1.12K | Buy |
+95
| New | +$1.12K | ﹤0.01% | 1623 |
|